NDT Plus Advance Access published online on November 17, 2009
NDT Plus, doi:10.1093/ndtplus/sfp162
Minimal change disease with interferon-beta therapy for relapsing remitting multiple sclerosis
1 Department of Nephrology, Liverpool Hospital
2 Department of Anatomical Pathology, Liverpool Hospital, Liverpool, NSW, Australia 2170
Correspondence: A. N. Aravindan; E-mail: aravindanan{at}gmail.com
| Abstract |
|---|
Interferon beta is widely used for the treatment of relapsing and remitting multiple sclerosis. Renal side effects including nephrotic syndrome have been increasingly described with interferon beta treatment. We describe an illustrative case of a patient who developed severe nephrotic syndrome due to minimal change disease in association with interferon beta therapy and showed partial remission following cessation of interferon beta and treatment with cortico- steroids.
Key Words: interferon beta minimal change disease nephrotic syndrome relapsing remitting multiple sclerosis
Received for publication October 11, 2009. Accepted for publication October 13, 2009.